Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - a Matrix Design

NCT00071266 is registered in ClinicalTrials.gov with Kos Pharmaceuticals as lead sponsor.

NCT NCT00071266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00071266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - a Matrix Design
Lead sponsor
Kos Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2003
Completion date
Not reported
Enrollment
870
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

intermittent claudication, peripheral vascular disease